123 related articles for article (PubMed ID: 35131366)
21. Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
Hu D; Zhang B; Yu M; Shi W; Zhang L
Mol Med Rep; 2020 Aug; 22(2):620-632. PubMed ID: 32468035
[TBL] [Abstract][Full Text] [Related]
22. Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types.
Hu A; Wang Y; Tian J; Chen Z; Chen R; Han X; Chen Y; Liu T; Chen Q
Front Oncol; 2022; 12():947054. PubMed ID: 36505822
[TBL] [Abstract][Full Text] [Related]
23. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract][Full Text] [Related]
24. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
[TBL] [Abstract][Full Text] [Related]
25. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
Pan HX; Bai HS; Guo Y; Cheng ZY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
[TBL] [Abstract][Full Text] [Related]
26. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
27. An integrated pan-cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity.
Liu JN; Kong XS; Sun P; Wang R; Li W; Chen QF
J Cell Mol Med; 2021 Feb; 25(4):2082-2097. PubMed ID: 33373169
[TBL] [Abstract][Full Text] [Related]
28. FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer.
Zhong A; Chen T; Xing Y; Pan X; Shi M
Front Immunol; 2021; 12():758648. PubMed ID: 34745134
[TBL] [Abstract][Full Text] [Related]
29. G-Protein Signaling Modulator 2 as a Potential Biomarker in Colorectal Cancer: Integrative Analysis Using Genetic Profiling and Pan-Cancer Studies.
Kadhim DJ; Azari H; Sokhangouy SK; Hassanian SM; Alshekarchi HI; Goshayeshi L; Goshayeshi L; Abbaszadegan MR; Khojasteh-Leylakoohi F; Khazaei M; Gataa IS; Peters GJ; A Ferns G; Batra J; Lam AK; Giovannetti E; Avan A
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674408
[TBL] [Abstract][Full Text] [Related]
30. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
31. The role of YTH domain containing 2 in epigenetic modification and immune infiltration of pan-cancer.
Zhang C; Guo C; Li Y; Ouyang L; Zhao Q; Liu K
J Cell Mol Med; 2021 Sep; 25(18):8615-8627. PubMed ID: 34312987
[TBL] [Abstract][Full Text] [Related]
32. RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers.
Tuo Z; Zhang Y; Wang X; Dai S; Liu K; Xia D; Wang J; Bi L
BMC Cancer; 2022 May; 22(1):523. PubMed ID: 35534796
[TBL] [Abstract][Full Text] [Related]
33. ZFC3H1, a zinc finger protein, modulates IL-8 transcription by binding with celastramycin A, a potential immune suppressor.
Tomita T; Ieguchi K; Coin F; Kato Y; Kikuchi H; Oshima Y; Kurata S; Maru Y
PLoS One; 2014; 9(9):e108957. PubMed ID: 25268596
[TBL] [Abstract][Full Text] [Related]
34. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.
Liang H; Zhang C; Li C; Li C; Wang Y; Lin H
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536
[TBL] [Abstract][Full Text] [Related]
35. Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma.
Chen B; Hu C; Jiang L; Xiang Z; Zuo Z; Lin Y; Liu C
Int Immunopharmacol; 2021 Mar; 92():107359. PubMed ID: 33465729
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer
Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Xin S; Zhang J
Front Endocrinol (Lausanne); 2021; 12():646793. PubMed ID: 34122331
[TBL] [Abstract][Full Text] [Related]
37. A pan-cancer analysis confirms PTPN11's potential as a prognostic and immunological biomarker.
Cao Y; Duan H; Su A; Xu L; Lai B
Aging (Albany NY); 2022 Jul; 14(13):5590-5610. PubMed ID: 35802774
[TBL] [Abstract][Full Text] [Related]
38. Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.
Zhang YP; Bao ZW; Wu JB; Chen YH; Chen JR; Xie HY; Zhou L; Wu J; Zheng SS
Technol Cancer Res Treat; 2020; 19():1533033820944274. PubMed ID: 32715976
[TBL] [Abstract][Full Text] [Related]
39. GLIS1, Correlated with Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer.
Peng Q; Xie T; Wang Y; Ho VW; Teoh JY; Chiu PK; Ng CF
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203661
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and therapeutic values of PMEPA1 and its correlation with tumor immunity in pan-cancer.
Wang B; Zhong JL; Li HZ; Wu B; Sun DF; Jiang N; Shang J; Chen YF; Xu XH; Lu HD
Life Sci; 2021 Jul; 277():119452. PubMed ID: 33831430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
